Tuesday 1 October 2019

Artificial Pancreas Device System Market Profile | Trend and SWOT Analysis | Forecast To 2023

Global Artificial Pancreas Device System Market Overview

The Artificial Pancreas Device Systems Market is projected to attain USD 341.08 million while progressing at a 21.10% CAGR in the period of the forecast says Market Research Future (MRFR). The requirement for safe and effective devices is the main factor impelling the demand for artificial pancreas device systems. Market reports connected with the healthcare industry have been made available by Market Research Future which generates reports on other business verticals that outlines the current market scenarios.

The prevalence of diseases like diabetes is motivating the growth of the market for artificial pancreas device system. The market draws considerable benefits from the increased investment being directed into the market to improve the product’s efficiency and efficacy. The device systems are a key step towards the treatment of ailments arising from the faulty function of the pancreas. Thus their advantages are crucial to the expansion of the market. The escalated level of innovations being bought about in the products is a direct result of the aptitude of the inventors and skilled professionals in the market. The continually rising expenditure on healthcare is projected to boost the market for artificial pancreas device system. Moreover, the rise in the geriatric population globally is expected to increase possibilities of growth for the market in the upcoming forecast period.


Segmental Analysis
The segmentation of the artificial pancreas device system market is carried out on the basis of type, end-user, and region. On the basis of type, the market is divided into CTT (Control To Target) Systems and CTR (Control to Range) Systems. The end users that are included in the artificial pancreas device system market are hospitals and medical centers. On the basis of Region, the artificial pancreas device system market encompasses regions such as North America, the Middle East, South America, Europe, Asia Pacific, and Africa.

Detailed Regional Analysis 
The regional analysis of the artificial pancreas device system market covers regions such as North America, the Middle East, South America, Europe, Asia Pacific, and Africa. As per the analysis, the North American region is growing effectively due to the contribution of the US, which accounts for the largest market share owing to the promising compensation scenario in the nation and increased expenditure on healthcare. Moreover, the quick market adoption of innovative technology in the US is also a significant factor for the growth of the market for artificial pancreas device systems globally. The European region is the demonstrating good growth due to the large level of disposable income and mounting awareness of the product offering of the market. The Asia Pacific region is anticipated to have the most latent for growth which is projected to be led by nations such as India and China. The Middle Eastern & African market is controlled by the Gulf countries chiefly such as Saudi Arabia and UAE. The underprivileged regions of the African region are expected to demonstrate slow progress owing to deprived economic conditions and reduced healthcare penetration.


Competitive Analysis

The positive trends witnessed in terms of the development of medical devices is spurring the growth of the artificial pancreas device system as well. The current outlook of the market is positive with a surge in the number of market contenders devoting funds to market development and innovations. The presence of strong contenders in the artificial pancreas device system market is expected to increase the impetus for growth in the coming years. The contenders in the artificial pancreas device system market are Medtronic Plc, Bigfoot Biomedical, Johnson & Johnson, Dexcom Inc., Cellnovo, Tandem Diabetes Care Inc., Pancreum Inc., TypeZero Technologies LLC, Beta Bionics, F. Hoffmann-La Roche Ltd, Inreda Diabetic B.V. and Insulet Corp to name a few.

Brows More Healthcare Related Research Reports:



For More Details Please Visit @ Market Research Future
at No comments:

Optical Coherence Tomography Market Profile | Dynamics and Key Players | Forecast To 2023

Optical Coherence Tomography (OCT) Market Overview

The Global Optical Coherence Tomography Market is likely to reach a significant valuation of USD 1483.49 Million by 2023 says Market Research Future (MRFR). Optical coherence tomography (OCT) is a non-invasive imaging technology used in attaining detailed images at a microscopic level. It employs near-infrared lighting to obtain clear images in real-time. The sharp rise noticed in eye-related diseases among the geriatric populace and industrial applications will induce the demand for OCT.

Market Outlook
The Global Optical Coherence Tomography Market valuation can touch USD 1483.9 million by 2023, as per the latest report by Market Research Future (MRFR). Technological advances in imaging devices coupled with high prevalence of macular disorders are likely to fuel the market growth.


Favorable medical reimbursement schemes regarding eye diseases and approval from regulatory agencies can propel the market to experience an 8.9% CAGR from 2017 to 2023 (forecast period). Furthermore, government support for the technology is likely to lead to an upturn in demand over the forecast period. Introduction of hybrid techniques such as optical coherence tomography angiography (OCTA) can open up new pathways for the market. In August 2018, Conavi Medical launched the Novasight hybrid system for scanning coronary arteries. It has been used on a trial basis by Hamilton General Hospital, Canada, to check its efficacy and performance.

Some of the prominent names in the optical coherence tomography market include NIDEK Co., Ltd., Carl Zeiss AG, Terumo Corporation, Agfa Healthcare, KONINKLIJKE PHILIPS N.V, Imalux Corporation, Optovue, Abbott Laboratories, Boston Scientific Corporation, OPTOPOL Technology S.A, B. Braun Melsungen AG, Michelson Diagnostics, Heidelberg Engineering GmbH, Alcon, Novacam Technologies Inc., Topcon Corporation, Thorlabs Inc., and others.
Launch of new products are certain to get exposure owing to social media and prevalence of chronic diseases. This is evident by the launch of AngioVue by OptoVue in 2016. The trend is indicative of the pressing demand owing to launch of similar products such as AngioScan OCT by Nidek, DRI-Triton and 3D Oct-1 Maestro by Topcon.
Get a Premium Sample Copy of “Optical Coherence Tomography Market” Research Report at 

Segmentation Analysis

The OCT market is segmented by technology, application, and device type.
By technology, spectral-domain OCT (SD-OCT), swept-source OCT, and others. The SD-OCT segment can command nearly 60.1% share of the OCT market by the end of the forecast period. On the other hand, the swept-source OCT segment can expand at a 9.1% CAGR over the aforementioned period.

Key applications of OCT include oncology, dermatology, ophthalmology, cardiology, and others. The ophthalmology segment can acquire close to 53.6% share of the market, while dermatology can grow at a brisk pace during the forecast period.

Types of OCT devices include tabletop OCT devices, catheter-based OCT devices, handheld OCT devices, and others.
Regions of prime interest to the market include The Americas, the Middle East & Africa (MEA), Asia Pacific (APAC), and Europe.


The Americas will lead the optical coherence tomography market owing to high ubiquitousness of diseases and presence of leading manufacturers. Prevalence of diabetic retinopathy and other age-related macular degeneration (AMD) are likely to induce demand for the market in the coming years. This market can touch a valuation of USD 558.34 million by 2023.

The Europe market has assumed the second position after Americas owing to funding gained for research & development by research institutes from governments and private sources. According to the 2017 report by the European Society of Retina Specialists (EURETINA), nearly 34 million suffer from AMD in the European Union.
The APAC OCT market is touted to grow at a rapid clip owing to technological advances in OCT devices. Growth opportunities in China, India, Malaysia, and other countries of South Asia and establishment of manufacturing units can bolster regional demand by 2023.

The MEA market can exhibit a sluggish growth rate during the forecast period owing to slowly developing economies in the African region.

Brows More Healthcare Related Research Reports:



For More Details Please Visit @ Market Research Future
at No comments:

Cosmetic Surgery Market Trend Analysis | Supply and Segmentation | Forecast To 2023

The Global Cosmetic Surgery Market has been growing persistently and is set to capture a CAGR of 7.8% over the forecast period of 2017-2023, reveals Market Research Future (MRFR) in a minutely analyzed research report. The global cosmetic surgery market has been observing continued growth on account of social and cultural factors such as the influence of social media and films. Interestingly, physical appearance is a social phenomenon, and the people are overwhelmingly driven to opt for cosmetic surgeries by the desire to look beautiful, flawless and young. Advertising and marketing are instrumental in shaping the cosmetic surgery market as they reinforce such beliefs among consumers which makes them indulge in cosmetic surgeries.

Photo filters available on applications such as Snapchat and Instagram have reportedly been vital in triggering body dysmorphic disorders among the youth who opt for cosmetic surgeries in an effort to look like an edited version of themselves. Rising disposable income levels in developing countries coupled with high adoption rates of invasive and minimally invasive cosmetic procedures drive the market majorly. Moreover, cosmetic surgeries are increasingly becoming affordable, and the trend of medical tourism has helped spur the growth of the market.


Technological developments in procedures and availability of skilled surgeons have helped consumers shake off their inhibitions regarding cosmetic surgeries. The rise in youth population is also a critical factor in propelling the market growth. The young population is more influenced by social media, changing beauty standards, peer pressure and form a large base of the cosmetic surgery consumers. On the downside, the side effects associated with cosmetic procedures and the high cost of cosmetic surgeries are significant market restraints. However, with more number of men opting for cosmetic procedures, the trend is likely to provide potential growth opportunities to the market. These factors in combination will help the market achieve a valuation of USD 21.97 Bn by the end of 2023.

Segmentation
The global cosmetic surgery market has been segmented based on surgery type which comprises liposuction, eyelid and nose surgery, body contouring, facial reconstruction, cosmetic implants and others. The body contouring segment has been further segmented into tummy tuck, breast lift, others. The cosmetic implants segment has been further segmented into breast augmentation, buttock implants, chin & cheek implants.


Regional Analysis
The global cosmetic surgery market spans across the regions of North America, Latin America, Europe, Asia Pacific and the Middle East & Africa. North America holds the maximum share of the market owing to an increase in awareness and growing acceptability of cosmetic surgery in the region, especially the US. Moreover, the region is technologically advanced which has resulted in the development of less painful and non-invasive procedures. The Asia Pacific region is expected to showcase relatively fast growth over the forecast period, with key contributions from Japan, India, and China. There is a shift towards Latin America and Asia Pacific for owing to medical tourism for cosmetic surgeries.

Competitive Landscape
The notable players in the global cosmetic surgery market include Johnson & Johnson, Cutera, Inc., Allergan, Inc., Valeant Pharmaceuticals International, Syneron Medical Ltd., Genesis Biosystems, Inc., and others.

Brows More Healthcare Related Research Reports:



For More Details Please Visit @ Market Research Future
at No comments:

Health Supplements Market SWOT Analysis | Capacity and Opportunities | Forecast To 2023

Global Health Supplements Market with 7.8% CAGR between 2017 and 2023, research report published by Market Research Future (MRFR). One of the most important reasons for their rising demand and hence market is that they are helpful for the treatment of rheumatic disorders, allergy, and cardiology.

Key factors that are driving this market include changing lifestyles, developing retail & pharmaceutical industries, ensuring adherence to recommended dietary requirements, growing awareness about the functional benefits of health supplements, growing concerns about maintenance of health to avoid later treatment, increasing concern towards health improvement, increasing urbanization, preventing occurrence of diseases, treating illnesses, peer pressure regarding health & fitness due to media, friends & family, and rapid advancements in product offerings.
The consumption of health supplements is increasing among consumers because they provide those nutrients to us on a regular basis which we do not regularly get in our food due to our food habits in a consumerist atmosphere. Hence, the market for health supplements is growing. Health supplements are supplements, not a replacement for food for a healthy diet.


The global health supplements market has been segmented on the basis of applications, end users, form, ingredients, types, and lastly region. On the basis of applications, this health supplements market has been segmented into allergy, cardiology, rheumatic disorders, and others. Based on end users, the health supplements market has been segmented into clinics, hospitals, research centers, and other. The form-based health supplements market segmentation into capsules, chewable, liquid syrups, tablets, and others. The ingredients-based segmentation of market comprises of amino acids, botanicals, enzymes, vitamins & minerals, and others. By types, the market has been segmented into bodybuilding supplements, dietary supplements, eye health supplements, specialty supplements, and others.

The regional segmentation of the global health supplements market covers The Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). The Americas hold the lion's share in the global market due to the presence of major key players in this region, especially in North America. Apart from big scale production, availability of funds for research, and government support for research & development (R & D) regarding the development of new health supplements which boosts the market. The market in the Americas is expected to grow during the forecast period.

The United States of America (USA) and Canada are expected to lead the market. Europe is the second largest position in the global health supplements market, due to the reasons same as the Americas. Due to technological advancement, North America and Western Europe are more advanced than South America and Eastern Europe, respectively. The cream of Europe market comprises of France, Germany, Italy, Spain, and the United Kingdom (UK), followed by rest of Europe.


The Asia Pacific is the fastest growing market due to the high healthcare expenditure, huge patient population, increasing demand for quality products, and presence of rapidly developing healthcare technology. The biggest markets in the Asia Pacific region comprise of Australia, China, India, Japan, and South Korea, followed by rest of the Asia Pacific region. In the MEA region, the market has a slow growth due to lack of available funds, education, lack of healthcare awareness, and political instability.

Key Players
The key players in the global health supplements market include Abbott Laboratories (USA), Alticor Inc. (USA), BASF SE (Germany), Bayer AG (Germany), E. I. du Pont de Nemours and Company (USA), Glanbia plc (Republic of Ireland), GlaxoSmithKline Limited (UK), Herbalife International (USA), and The Nature's Bounty Co. (USA).

Brows More Healthcare Related Research Reports:



For More Details Please Visit @ Market Research Future
at No comments:
Subscribe to: Posts (Atom)

Ultra-low Temperature Freezers Market Profile, Trends and Applications By 2027

  According to the MRFR reports, the global   ultra-low temperature freezers market   is projected to acquire a market size of approximately...